Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses

By Mooney Alaina J   Tompkins S Mark  

Future Virology, Vol. 8, Iss. 1, 2013-01 ,pp. : 25-41

Future Medicine

Access to resources Recommend Favorite

Oseltamivir/zanamivir: Development of neuraminidase inhibitor resistance in influenza A virus H1N1 subtype in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1326, 2010-01 ,pp. : 26-27

Adis International

Access to resources Recommend Favorite

Oseltamivir in Seasonal, Avian H5N1 and Pandemic 2009 A/H1N1 Influenza: Pharmacokinetic and Pharmacodynamic Characteristics

By Widmer Nicolas  

Clinical Pharmacokinetics, Vol. 49, Iss. 11, 2010-11 ,pp. : 741-765

Adis International

Access to resources Recommend Favorite

Emergence of Oseltamivir Resistance: Control and Management of Influenza before, during and after the Pandemic

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 13, Iss. 1, 2013-02 ,pp. : 34-45

Bentham Science Publishers

Access to resources Recommend Favorite

Epidemiological Aspects of Seasonal and Pandemic Influenza in Recent Years and Emerging Viruses

By  

Clinical Immunology, Endocrine & Metabolic Drugs, Vol. 3, Iss. 1, 2016-06 ,pp. : 15-24

Bentham Science Publishers

Access to resources Recommend Favorite